Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heat shock protein family B member 1 pseudogene 1 (HSPB1P1) is a non-protein-coding pseudogene, derived from the parental HSPB1 gene, which encodes heat shock protein beta-1. While HSPB1P1 does not produce a functional protein, it is abnormally expressed across multiple human cancers. Elevated HSPB1P1 RNA levels are correlated with cancer progression and poor prognosis, particularly in hepatocellular carcinoma. Functional studies indicate that HSPB1P1 may regulate gene expression by acting as a ceRNA, modulating pathways such as EZH2 signaling in cancer. It is not a traditional therapeutic target but may serve as a prognostic biomarker and a candidate for future RNA-based therapies.
As a pseudogene, HSPB1P1 may act as a regulatory RNA affecting expression of other genes (such as EZH2 in hepatocellular carcinoma) through ceRNA mechanisms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat shock protein family B member 1 pseudogene 1 (HSPB1P1).